Table 4.
Recurrent endometrial cancer deaths by therapy at time of recurrence
| Clinicopathologic factor | No additional treatment n = 27 | Treatment at time of recurrence n = 35 | p value |
|---|---|---|---|
| Age at surgery | |||
| Mean (SD) | 70.04 (8.074) | 64.57 (9.799) | .03 |
| Median | 71 | 66 | |
| Histology | |||
| Endometrioid | 11 | 14 | NS |
| Serous | 7 | 13 | |
| Mixed | 2 | 3 | |
| Carcinosarcoma | 5 | 5 | |
| Undifferentiated/dedifferentiated | 1 | 0 | |
| Mucinous | 0 | 0 | |
| Clear cell | 1 | 0 | |
| FIGO grade, endometrioid only | |||
| 1 | 4 | 9 | NS |
| 2 | 4 | 1 | |
| 3 | 3 | 4 | |
| Stage | NS | ||
| I | 7 | 9 | |
| II | 0 | 2 | |
| III | 17 | 10 | |
| IV | 3 | 14 | |
| Adjuvant therapy received | NS | ||
| Yes | 22 | 29 | |
| No | 5 | 6 | |
| MMR status | NS | ||
| Intact | 16 | 26 | |
| Deficient | 11 | 9 |
Abbreviations: FIGO, International Federation of Gynecology and Obstetrics; MMR, mismatch repair; NS, not significant.